Healthcare Sales & Marketing Network News: Fovea Pharmaceuticals

Searching News Database: Fovea Pharmaceuticals

HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 27 Nov 2012
Kala Pharmaceuticals Appoints Dr. Bernard Gilly to Its Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 5 Aug 2010
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 1 Dec 2009
Dyax Announces FDA Approval of KALBITOR(R) (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 18 Jun 2008
Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2007
Fovea Pharmaceuticals Completes EUR30M Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Nov 2007
Orexo Acquires Biolipox
Biopharmaceuticals Mergers & Acquisitions

Return to NewsFeed

Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 1 additional stories matching:
Fovea Pharmaceuticals
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.